AUTONOMIX MEDICAL INC (AMIX) Stock Price & Overview

NASDAQ:AMIXUS05330T2050

Current stock price

0.3803 USD
-0.02 (-4.9%)
At close:
0.3693 USD
-0.01 (-2.89%)
After Hours:

The current stock price of AMIX is 0.3803 USD. Today AMIX is down by -4.9%. In the past month the price decreased by -9.88%. In the past year, price decreased by -77.44%.

AMIX Key Statistics

52-Week Range0.3415 - 2.82
Current AMIX stock price positioned within its 52-week range.
1-Month Range0.3701 - 0.4699
Current AMIX stock price positioned within its 1-month range.
Market Cap
4.339M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-4.62
Dividend Yield
N/A

AMIX Stock Performance

Today
-4.9%
1 Week
-3.60%
1 Month
-9.88%
3 Months
-25.75%
Longer-term
6 Months -65.74%
1 Year -77.44%
2 Years -99.41%
3 Years N/A
5 Years N/A
10 Years N/A

AMIX Stock Chart

AUTONOMIX MEDICAL INC / AMIX Daily stock chart

AMIX Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to AMIX. When comparing the yearly performance of all stocks, AMIX is a bad performer in the overall market: 95.04% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AMIX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AMIX. No worries on liquidiy or solvency for AMIX as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AMIX Earnings

Next Earnings DateN/A
Last Earnings DateFeb 11, 2026
PeriodQ3 / 2026
EPS Reported-$0.36
Revenue Reported
EPS Surprise 39.67%
Revenue Surprise %

AMIX Forecast & Estimates

8 analysts have analysed AMIX and the average price target is 5.2 USD. This implies a price increase of 1267.87% is expected in the next year compared to the current price of 0.3803.


Analysts
Analysts85
Price Target5.2 (1267.34%)
EPS Next Y-78.87%
Revenue Next YearN/A

AMIX Groups

Sector & Classification

Index Membership

AMIX Financial Highlights

Over the last trailing twelve months AMIX reported a non-GAAP Earnings per Share(EPS) of -4.62. The EPS increased by 68.27% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-17.24M
Industry RankSector Rank
PM (TTM) N/A
ROA -168.84%
ROE -201.38%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%75.34%
Sales Q2Q%N/A
EPS 1Y (TTM)68.27%
Revenue 1Y (TTM)N/A

AMIX Ownership

Ownership
Inst Owners2.51%
Shares11.41M
Float10.95M
Ins Owners3.01%
Short Float %1.84%
Short Ratio0.96

About AMIX

Company Profile

AMIX logo image Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. The company is headquartered in The Woodlands, Texas and currently employs 8 full-time employees. The company went IPO on 2024-01-29. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The firm is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.

Company Info

IPO: 2024-01-29

AUTONOMIX MEDICAL INC

21 Waterway Ave, Suite 300

The Woodlands TEXAS US

Employees: 10

AMIX Company Website

AMIX Investor Relations

Phone: 18322777816

AUTONOMIX MEDICAL INC / AMIX FAQ

Can you describe the business of AUTONOMIX MEDICAL INC?

Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. The company is headquartered in The Woodlands, Texas and currently employs 8 full-time employees. The company went IPO on 2024-01-29. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The firm is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.


Can you provide the latest stock price for AUTONOMIX MEDICAL INC?

The current stock price of AMIX is 0.3803 USD. The price decreased by -4.9% in the last trading session.


What is the dividend status of AUTONOMIX MEDICAL INC?

AMIX does not pay a dividend.


What is the ChartMill rating of AUTONOMIX MEDICAL INC stock?

AMIX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What sector and industry does AUTONOMIX MEDICAL INC belong to?

AUTONOMIX MEDICAL INC (AMIX) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is AUTONOMIX MEDICAL INC worth?

AUTONOMIX MEDICAL INC (AMIX) has a market capitalization of 4.34M USD. This makes AMIX a Nano Cap stock.